[HTML][HTML] Critical Parameters for the Development of Novel Therapies for Severe and Resistant Infections—A Case Study on CAL02, a Non-Traditional Broad-Spectrum …
S Azeredo da Silveira, AF Shorr - Antibiotics, 2020 - mdpi.com
Background: Poor outcomes in severe and resistant infections, together with the economic
struggles of companies active in the field of anti-infective development, call for new solutions …
struggles of companies active in the field of anti-infective development, call for new solutions …
Effect of a novel extracorporeal cytokine apheresis method on endocan, copeptin And interleukin-6 levels in sepsis: An observational prospective study
Purpose There is still an evident need for useful biomarkers and effective therapeutic
approaches regarding the challenging management of sepsis. The aim of the study is to …
approaches regarding the challenging management of sepsis. The aim of the study is to …